NOXXON to Launch NOX-A12 with Radiotherapy Clinical Trial in Patients with Brain Cancer
NOXXON Pharma N.V. (Paris:ALNOX) (Euronext...
Read MoreNOXXON Pharma N.V. (Paris:ALNOX) (Euronext...
Read MoreTakeda Pharmaceutical Company Limited (“Takeda”)...
Read MoreMedivir AB (Nasdaq Stockholm: MVIR) today...
Read MoreAbbott (NYSE:ABT) said yesterday that it...
Read MoreSandoz, a Novartis division, and...
Read MoreFood and Drug Administration approved...
Read MoreBTG develops products that are...
Read MoreIpsen and 3BP today announced...
Read MoreHealthhunt, a leading and highly-engaging...
Read MoreWuXi AppTec announces today that...
Read More